Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)
Amy Body(Monash Health), Eva Segelov(University of Bern), C. Mee Ling Munier(UNSW Sydney), Elizabeth Ahern(Monash Health), Tracey O’Brien(Sydney Children's Hospital), Stuart Turville(UNSW Sydney), Karen Gillett(Monash Health), Hesham Abdulla(Suez Canal University), C. Raina MacIntyre(UNSW Sydney), Luxi Lal(Monash Health), Stephen Opat(Monash Health), Peter Downie(Monash Children’s Hospital), Corey Smith(QIMR Berghofer Medical Research Institute)
Cited by 7
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
|Blood|2019|369
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261